ShareTreck: Jeff Galvin Weighs in on Addimmune’s Launch and AGT103-T Updates

Posted By: AGT, On: Jun 22, 2023

Filed Under: In The News

American Gene Technologies® CEO Jeff Galvin joins ShareTreck host Raj Natarajan in this compelling interview to share updates on AGT103-T, as well as the launch of the new HIV-focused spinoff company – Addimmune. Following a successful Phase 1 clinical trial, Addimmune will build AGT’s success, accelerating the clinical development with dedicated investment and singular focus on HIV.

Watch Video Here

Subscribe to Press Release and News Updates

Subscribe to our press release and published article updates to be notified when we release new content!